Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Retatrutide: Complication Focus TRIUMPH-4: Obesity + knee osteoarthritis (445 participants) TRIUMPH-2: Obesity + type 2 diabetes TRIUMPH-6: Weight maintenance trial Advantage: Multiple complication-specific trials could lead to broader label (obesity + OA + OSA indications)
Key Research Properties: Small molecule NNMT (nicotinamide N-methyltransferase) inhibitor Modulates NAD+ metabolism and methylation capacity Studied in context of energy expenditure and metabolic regulation NNMT is upregulated in obesity
Most are not
delivery Fri, Jul 31Thu, Aug 6 COA included Same-day ship before 2PM PT Apple Pay Google Pay Visa Amex Discover Compound information Technical specifications for laboratory reference Molecular profile Research blend of cagrilintide with tirzepatide-class dual GIP/GLP-1 agonist for multi-receptor signaling studies in vitro
A Tripeptide from Human Serum Which Enhances the Growth of Neoplastic Hepatocytes and the Survival of Normal Hepatocytes. Nature New Biology, 243(124), 8587
Growth Hormone Receptor Upregulation GHR/JAK2 Pathway Research confirmed that BPC-157 dose- and time-dependently increases the expression of the growth hormone receptor (GHR) in tendon fibroblasts at both the mRNA and protein level
US$ 20.57
US$ 23.12
US$ 27.43
US$ 25.00
US$ 28.68
US$ 29.96
US$ 29.84
